IZONRO Trademark
Serial Number: 79352080 • Registration: 7129122
IZONRO is a trademark filed by
NOVARTIS AG
on July 14, 2022. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Maury M. Tepper, III Tepper & Eyster, PLLC
3724 BENSON DR
RALEIGH
NC 27609
United States
Trademark Details
Filing Date
July 14, 2022
Registration Date
August 8, 2023
Published for Opposition
May 23, 2023
Filing History
CHANGE OF OWNER RECEIVED FROM IB
Jan 19, 2024 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 11, 2023 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Nov 13, 2023 FICS
FINAL DISPOSITION PROCESSED
Nov 13, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 8, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 8, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 8, 2023 R.PR
NOTIFICATION PROCESSED BY IB
May 24, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 23, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 23, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 3, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 3, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 3, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 17, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 17, 2023 CRFA
ASSIGNED TO LIE
Apr 17, 2023 ALIE
REFUSAL PROCESSED BY IB
Feb 7, 2023 RFNT
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 20, 2023 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 18, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 18, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 8, 2022 RFCR
NON-FINAL ACTION WRITTEN
Nov 7, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 3, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 25, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 20, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 13, 2022 REPR
